Condition

Relapsing Multiple Sclerosis clinical trials and research

• 9Clinical trials
• 22Countries

Newest Relapsing Multiple Sclerosis clinical trials

All recruiting trials (9)

• Ublituximab in Pediatric Relapsing MS: See if a B-cell therapy works in kids

  This study tests whether ublituximab can work in children and teens with relapsing MS and compares it to fingolimod in eligible participants.

  Recruiting at 5 sites Phase 2/3 TG Therapeutics, Inc. · Salt Lake City, Utah and 5 other locations · NCT07220252

• Fenebrutinib for relapsing multiple sclerosis in children and adolescents (ages 10 to <18).

  This study will test fenebrutinib in children and adolescents ages 10 to under 18 with relapsing multiple sclerosis to measure how the drug behaves in the body and whether it is safe and well tolerated.

  Recruiting at 17 sites Phase 2 Hoffmann-La Roche · Rosario, Santa Fe Province and 16 other locations · NCT07161258

• Remibrutinib after switching from ocrelizumab for relapsing multiple sclerosis

  This study will see if remibrutinib, a daily oral BTK inhibitor, keeps relapsing MS under control in people switching from ocrelizumab compared with continuing ocrelizumab.

  Recruiting at 128 sites Phase 3 Novartis · Scottsdale, Arizona and 130 other locations · NCT06846281

• Evaluating ozanimod for stable MS patients previously treated with anti-CD20 therapies

  This study is testing if switching to a new medication called ozanimod can be a safe and effective option for stable multiple sclerosis patients who have been using anti-CD20 therapies.

  Recruiting at 3 sites Phase 4 University of Colorado, Denver · Aurora, Colorado and 2 other locations · NCT06529406

• Evaluating real-world experiences of patients treated with BRIUMVI® for relapsing multiple sclerosis

  This study is looking to see how well BRIUMVI® works and what side effects it has for people with relapsing multiple sclerosis in everyday settings.

  Recruiting at 113 sites TG Therapeutics, Inc. · Birmingham, Alabama and 112 other locations · NCT06433752

• Evaluating a modified treatment regimen of ublituximab for relapsing multiple sclerosis

  This study is testing a new way to use ublituximab to see if it can help people with relapsing multiple sclerosis feel better and stay safe.

  Recruiting at 49 sites Phase 3 TG Therapeutics, Inc. · Birmingham, Alabama and 50 other locations · NCT05877963

• Observing the effects of Ofatumumab in Portuguese patients with relapsing multiple sclerosis

  This study is testing how well Ofatumumab works for Portuguese patients with relapsing multiple sclerosis who started treatment either within three years of their diagnosis or after, to see if it helps them stay symptom-free.

  Recruiting at 10 sites Novartis · Amadora and 9 other locations · NCT05809986

• Observing people with relapsing MS who start approved injectable or selected oral disease-modifying treatments

  This project will test how approved injectable and certain oral MS treatments work for adults with relapsing MS receiving routine care in Germany.

  Recruiting at 78 sites Novartis · Albstadt, Baden-Wurttemberg and 140 other locations · NCT05344469

• Comparing stem cell transplant to best available therapy for treatment-resistant multiple sclerosis

  This study is testing if a stem cell transplant can help people with treatment-resistant multiple sclerosis feel better compared to the best available therapies.

  Recruiting at 19 sites Phase 3 National Institute of Allergy and Infectious Diseases (NIAID) · Palo Alto, California and 22 other locations · NCT04047628

Related topics

Quick answers

How many Relapsing Multiple Sclerosis clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 22 countries. The most sites are in United States (6 trials), Portugal (3 trials), Poland (3 trials), Argentina (2 trials), Brazil (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 2/3: 1, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →